The effect of multidrug-resistance 1 gene versus neo transduction on ex vivo and in vivo expansion of rhesus macaque hematopoietic repopulating cells

被引:43
作者
Sellers, SE
Tisdale, JF
Agricola, BA
Metzger, ME
Donahue, RE
Dunbar, CE
Sorrentino, BP
机构
[1] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
[2] NIDDKD, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA
[3] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA
关键词
D O I
10.1182/blood.V97.6.1888
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transduction of murine stem cells with a multidrug-resistance 1 gene (MDR1) retrovirus results in dramatic ex vivo and in vivo expansion of repopulating cells accompanied by a myeloproliferative disorder, Given the use of MDR1-containing vectors in human trials, investigations have been extended to nonhuman primates, Peripheral blood stem cells from 2 rhesus monkeys were collected, CD34-enriched, split into 2 portions, and transduced with either MDR1 vectors or neo vectors and continued in culture for a total of 10 days before reinfusion. At engraftment, the copy number in granulocytes was extremely high from both MDR vectors and neo vectors, but the copy number fell to 0.01 to 0.05 for both. There were no perturbations of the leukocyte count or differential noted. After 3 cycles of stem cell factor/granulocyte colony-stimulating factor, there were no changes in the levels of MDR1 vector- or neo vector-containing cells. There was no evidence for expansion of MDR1 vector-transduced cells. Longterm engraftment with MDR1 vector- and neo vector-transduced cells occurred de spite prolonged culture. (Blood. 2001;97: 1888-1891) (C) 2001 by The American Society of Hematology.
引用
收藏
页码:1888 / 1891
页数:4
相关论文
共 20 条
  • [1] ANTIGEN CD34+ MARROW-CELLS ENGRAFT LETHALLY IRRADIATED BABOONS
    BERENSON, RJ
    ANDREWS, RG
    BENSINGER, WI
    KALAMASZ, D
    KNITTER, G
    BUCKNER, CD
    BERNSTEIN, ID
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (03) : 951 - 955
  • [2] Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo
    Bunting, KD
    Zhou, S
    Lu, TH
    Sorrentino, BP
    [J]. BLOOD, 2000, 96 (03) : 902 - 909
  • [3] Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice
    Bunting, KD
    Galipeau, J
    Topham, D
    Benaim, E
    Sorrentino, BP
    [J]. BLOOD, 1998, 92 (07) : 2269 - 2279
  • [4] CASSEL A, 1993, EXP HEMATOL, V21, P585
  • [5] Cowan KH, 1999, CLIN CANCER RES, V5, P1619
  • [6] Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells
    Dao, MA
    Hashino, K
    Kato, I
    Nolta, JA
    [J]. BLOOD, 1998, 92 (12) : 4612 - 4621
  • [7] Peripheral blood CD34(+) cells differ from bone marrow CD34(+) cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor
    Donahue, RE
    Kirby, MR
    Metzger, ME
    Agricola, BA
    Sellers, SE
    Cullis, HM
    [J]. BLOOD, 1996, 87 (04) : 1644 - 1653
  • [8] RETROVIRALLY MARKED CD34-ENRICHED PERIPHERAL-BLOOD AND BONE-MARROW CELLS CONTRIBUTE TO LONG-TERM ENGRAFTMENT AFTER AUTOLOGOUS TRANSPLANTATION
    DUNBAR, CE
    COTTLERFOX, M
    OSHAUGHNESSY, JA
    DOREN, S
    CARTER, C
    BERENSON, R
    BROWN, S
    MOEN, RC
    GREENBLATT, J
    STEWART, FM
    LEITMAN, SF
    WILSON, WH
    COWAN, K
    YOUNG, NS
    NIENHUIS, AW
    [J]. BLOOD, 1995, 85 (11) : 3048 - 3057
  • [9] Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy
    Hanania, EG
    Giles, RE
    Kavanagh, J
    Ellerson, D
    Zu, Z
    Wang, T
    Su, Y
    Kudelka, A
    Rahman, Z
    Holmes, F
    Hortobagyi, G
    Claxton, D
    Bachier, C
    Thall, P
    Cheng, S
    Hester, J
    Ostrove, JM
    Bird, RE
    Chang, A
    Korbling, M
    Seong, D
    Cote, R
    Holzmayer, T
    Mechetner, E
    Heimfeld, S
    Berenson, R
    Burtness, B
    Edwards, C
    Bast, R
    Andreeff, M
    Champlin, R
    Deisseroth, AB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (26) : 15346 - 15351
  • [10] Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation
    Hesdorffer, C
    Ayello, J
    Ward, M
    Kaubisch, A
    Vahdat, L
    Balmaceda, C
    Garrett, T
    Fetell, M
    Reiss, R
    Bank, A
    Antman, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 165 - 172